Search results for: 'cancer cell analyst'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent innovations cross immunotherapies, precision medicine, cancer treatment, cell engineering, liquid biopsy and AI-enabled drug discovery and development. The TOE also highlights recent advances in implantables, ophthalmology, neurop...

Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...

This research service analyzes the U.S. cancer biomarker testing market from 2009 to 2017. Topics include an overview of the market, along with definitions, metrics, drivers, and restraints. Also offered is an evaluation of ongoing technology trends and major market competitors and their corresponding market shares and product offerings. Based on t...

Data breaches have risen in scale and complexity, and enterprises are investing in many solutions to address each new threat exposure. Often, such solutions operate in silos, generating alerts on multiple threat types. The security operations center (SOC) must handle and respond to each alert; when done manually, speed and accuracy suffer. SOCs con...

Third-generation photovoltaics represent a fundamental shift in how solar energy is harvested, integrated, and scaled—moving beyond conventional silicon toward tunable, lightweight, and application-specific photovoltaic materials. By advancing perovskite, organic, tandem, and quantum-dot architectures, the industry is unlocking new capabilities in ...

This research service investigates technologies that propel the development of new targeted immunotherapies, particularly those that deliver therapeutic DNA and proteins. The top 3 growth opportunities focus on enhanced gene delivery systems for greater precision, the support of such systems through novel biotech platforms, and the affordability of...

Emerging Therapeutics in the U.S. Colorectal Cancer Market is a rapidly progressing field that is set to generate over $2 billion in revenue in the coming years. The market has witnessed unprecedented growth with the launch of a new segment and as a result competition has increased in the cytotoxic market. The dynamics of this market are changing...

Basal media, fetal bovine media, and balanced salt solutions are prevalent cell culture media. However, serum free media and growth, as well as attachment factors, are expected to see increased use in 2013 because current non-users are planning to include them in their workflow. Overall, Asia-Pacific is still a growing market in terms of the numbe...

31 Jul 2023  |  North America  |  Market Research

Global Oncology Diagnostics in IVD Growth Opportunities

By Leveraging Data-driven Solutions, Co-development Opportunities, and Assay Innovation, Clients Can Experience Enhanced Product Performance, Cost-effectiveness, and Improved Decision-making Capabilities

Infographics

×

The global oncology diagnostics in IVD market is expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, the most prominent companies are investing h...